Proceedings of an expert workshop on community agreement for gene drive research in Africa - Co-organised by KEMRI, PAMCA and Target Malaria. by Thizy, Delphine et al.
OPEN LETTER
   Proceedings of an expert workshop on community 
agreement for gene drive research in Africa - Co-organised by 
KEMRI, PAMCA and Target Malaria [version 2; peer review: 2 
approved]
Delphine Thizy 1*, Lea Pare Toe2*, Charles Mbogo 3,4*, 
Damaris Matoke-Muhia 4,5*, Vincent Pius Alibu6*, S. Kathleen Barnhill-Dilling 7*, 
Tracey Chantler 8*, Gershom Chongwe 9*, Jason Delborne 7*, Lydia Kapiriri10*, 
Esther Nassonko Kavuma 11*, Sethlomo Koloi-Keaikitse12*, Ana Kormos 13*, 
Katherine Littler14*, Dickson Lwetoijera15*, Roberta Vargas de Moraes16*, 
Noni Mumba3*, Lilian Mutengu17*, Sylvia Mwichuli18*, 
Silvia Elizabeth Nabukenya19*, Janet Nakigudde20*, Paul Ndebele 21*, 
Carolyne Ngara22*, Eric Ochomo 23*, Simon Odiwuor Ondiek3*, 
Stephany Rivera16*, Aaron J. Roberts 16*, Benjamin Robinson 24*, 
Rodrick Sambakunsi25*, Abha Saxena26,27*, Naima Sykes1*, Brian B. Tarimo 28*, 
Nicki Tiffin 29*, Karen H. Tountas30*
1Imperial College London, London, UK 
2Institut de Recherche en Science de la Santé, Ouagadougou, Burkina Faso 
3Kenyan Institute of Medical Research, Kilifi, Kenya 
4Pan African Mosquito Control Association, Nairobi, Kenya 
5Kenyan Institute of Medical Research, Nairobi, Kenya 
6Makerere University, Kampala, Uganda 
7North Carolina State University, Raleigh, USA 
8London School of Hygiene & Tropical Medicine, London, UK 
9Tropical Diseases Research Centre, Ndola, Ndola, Zambia 
10Department of Health, Ageing and Society, McMaster University, Hamilton, Canada 
11Jenak Investments Limited, Kampala, Uganda 
12faculty of education, University of Botswana, Gaborone, Botswana 
13University of California Irvine Malaria Initiative, Irvine, USA 
14Global Health Ethics Unit, World Health Organization, Geneva, Switzerland 
15Ifakara Health Institute, Dar-Es-Salaam, Tanzania 
16Institute on Ethics and Policy for Innovation, Faculty of Humanities, McMaster University, Hamilton, Canada 
17African Academy of Sciences, Nairobi, Kenya 
18International Center for Evaluation and Development, nairobi, Kenya 
19Infectious Diseases Institute, Kampala, Uganda 
20College of Health Sciences, Makerere University, Kampala, Uganda 
21Milken Institute School of Public Health, George Washington University, Washington DC, USA 
22Wellcome Trust,UK, London, UK 
23Kenyan Institute of Medical Research, Kisumu, Kenya 
24Emerging Ag., Calgary, Alberta, Canada 
25Malawi Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi 
Gates Open Research
 
Page 1 of 15
Gates Open Research 2021, 5:19 Last updated: 12 APR 2021
26The INCLEN Trust International, Delhi, India 
27Institut Ethique Histoire Humanités, University of Geneva, Geneva, Switzerland 
28Vector Immunity and Transmission Biology Unit, Department of Environmental Health and Ecological Sciences,, ifakara Health 
Institute, Bagamoyo, Tanzania 
29Division of Computational Biology, and Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, Cape 
Town, South Africa 
30Foundation for the National Institutes of Health, Bethesda, USA 
* Equal contributors
First published: 29 Jan 2021, 5:19  
https://doi.org/10.12688/gatesopenres.13221.1





Gene drive research is progressing towards future field evaluation of 
modified mosquitoes for malaria control in sub-Saharan Africa. While 
many literature sources and guidance point to the inadequacy of 
individual informed consent for any genetically modified mosquito 
release, including gene drive ones, (outside of epidemiological studies 
that might require blood samples) and at the need for a community-
level decision, researchers often find themselves with no specific 
guidance on how that decision should be made, expressed and by 
whom. Target Malaria, the Kenya Medical Research Institute and the 
Pan African Mosquito Control Association co-organised a workshop 
with researchers and practitioners on this topic to question the model 
proposed by Target Malaria in its research so far that involved the 
release of genetically modified sterile male mosquitoes and how this 
could be adapted to future studies involving gene drive mosquito 
releases for them to offer reflections about potential best practices. 
This paper shares the outcomes of that workshop and highlights the 
remaining topics for discussion before a comprehensive model can be 
designed.
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Background
Recent scientific advances in the field of gene drive research 
have increased the likelihood that gene drive-modified mosqui-
toes to reduce the burden of malaria will be proposed for field 
evaluation in the near-to-medium-term future. This technology 
is considered a potentially transformative tool for malaria 
elimination (Feachem et al., 2019; World Health Organization, 
2020a), due to some of its characteristics including the absence 
of behaviour change associated with it, its egalitarian nature 
and its ability to cover hard-to-reach locations. As several of the 
leading research teams in this field are currently working in 
Africa, where the burden of malaria is most significant (World 
Health Organization, 2020c), interest on that continent in the 
research is particularly strong (African Union, 2018).
Stakeholder engagement is an essential part of responsible 
gene drive research (James et al., 2018; National Academies of 
Sciences Engineering and Medicine, 2016; Resnik, 2018) and 
increasingly for all public health research and in particular that on 
vector-borne diseases. However, because genetic approaches and 
gene drive specifically are reasonably new area-wide technolo-
gies in the field of vector control, many theoretical and practical 
components of ethical and effective engagement strategies 
remain subject to debate. Those discussions are not specific 
to gene drive, they apply to other genetic approaches and to 
other area-wide vector control measures, but gene drive tech-
nologies seem to have put this question under a new spotlight 
(World Health Organization, 2020b). While area-wide control 
technologies can offer the benefit of providing vector control 
for all inhabitants of a specific area without individual or group 
biases related to economic status, education or social position, 
it may not be possible for individuals within a given community 
to opt-out of field evaluations. The World Health Organisation 
(WHO) Guidance framework for testing genetically modified 
mosquitoes clearly establishes that individual consent is not 
appropriate for the open release of genetically-modified mosqui-
toes unless there is a collection of samples or data from human 
participants to track epidemiological results, in which cases those 
collections require individual consent (WHO/TDR and FNIH, 
2014). Instead, the WHO guidance calls for “community authori-
sation” prior to the release of genetically modified mosquitoes. 
However, there is currently no established consensus on 
definitions or guidelines related to community authorisation in 
gene drive research, or on how research teams should approach 
these issues in preparation for field evaluations.
Given their shared interest in the issue of malaria control 
and shared expertise in community and stakeholder engagement, 
Target Malaria, Kenya Medical Research Institute (KEMRI), 
and Pan African Mosquito Control Association (PAMCA) 
partnered to convene experts and researchers to discuss the 
question of how to approach community acceptance for field 
evaluations of gene drive mosquitoes.
As one of the leading research projects in the field of gene 
drive mosquitoes for malaria control, and to support its 
commitment to conduct its research according to the best 
scientific and ethical standards and practices, Target Malaria has 
actively undertaken outreach to other research groups – such as 
those working on Wolbachia approaches for diseases transmit-
ted by Aedes mosquitoes such as the World Mosquito Programme 
or the National Environment Agency of Singapore or other 
groups working on vector control in Africa such as KEMRI, 
Ifakara Health Institute – and to additional experts on stake-
holder engagement, deliberative dialogue and bioethics to help 
co-develop and establish best practices for stakeholder engage-
ment. It has already collaborated with partners on the broader 
questions of best practices for stakeholder engagement for the 
research and development of genetically modified mosquitoes 
(incl. releases), resulting in the publication of several papers on 
the subject (Barry et al., 2020; Hartley et al., 2019; Thizy et al., 
2019) documenting its approach to co-development, the work 
with local communities, and proposing guidance for technology 
developers in gene drive research and other fields.
Kenya Medical Research Institute: KEMRI is a State Corporation 
responsible for carrying out research for human health in 
Kenya. KEMRI’s mandate is to oversee the research activi-
ties with a view to providing advice and direction for national 
development. KEMRI provides leadership in health research 
& development, shaping the health research agenda, setting 
norms and standards, articulating evidence-based policy options 
and monitoring and assessing health trends. In addition, KEMRI 
deals with trans-boundary threats and disease outbreaks. The 
safe and ethical development of new technologies relevant 
to public health, therefore, falls under its remit. KEMRI has 
developed a critical mass of scientists, technical and admin-
istrative support staff to rank as one of the leading centres of 
excellence in health research and development in the African 
region and beyond.
Pan African Mosquito Control Association: PAMCA is an 
African professional body that brings together actors in the field 
of vectors and vector-borne disease control. PAMCA exists to 
provide a platform for capacity building, knowledge sharing 
and collaboration for concerted vector control initiatives in the 
African continent. The mission of PAMCA is to provide a 
platform for Africa-based scientists, public health professionals 
and other stakeholders to drive efforts towards control and 
elimination of mosquito-borne diseases. PAMCA has an increas-
ing number of well-trained entomologists distributed across 
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the continent who help to address local problems with locally 
adapted solutions and through partnerships between national 
mosquito control programs, research institutions, product devel-
opment companies and funders involved in mosquito control 
on the continent. Since 2017, PAMCA has partnered with 
Target Malaria to train more than 60 early-career scientists on 
gene drive technology and its application for malaria control.
The objective of this expert workshop on community agreement 
for gene drive research in Africa was to provide direction and 
recommendations to Target Malaria and beyond the project offer 
some reflections for other projects, specifically on the question 
of community acceptance and consent for possible future field 
evaluations of gene drive-modified mosquitoes.
While the purposes of stakeholder engagement are multiple and 
go well beyond seeking acceptance of the technology and 
field trials, researchers must grapple with what constitutes 
meaningful acceptance as this is a requirement for their research 
to be able to proceed. The workshop aimed to clarify what is 
meant by agreement, consent and acceptance, what practices, 
requirements and standards could be drawn upon by Target 
Malaria to ensure decisions are informed and meaningful, and 
what are the responsibilities and roles of researchers and 
other actors in this process.
Workshop description
The workshop was intended both to inform Target Malaria’s 
work and to build a community of practice that the project 
can refer to in future as it seeks guidance. Participants were 
drawn from the professional networks of Target Malaria, KEMRI, 
and PAMCA based on relevant expertise, experience, and 
interest, while ensuring regional and gender balance. After an 
initial briefing that provided overviews on gene drive technology 
and Target Malaria’s community consent model and experience 
to-date, structured discussions took place over a 5-week period, 
hosted on the MESH Community Engagement Network (MESH), 
a networking and dialogue space for researchers focused 
on community engagement and global health. Each participant 
is included in the author list or in the acknowledgements.
MESH-hosted discussions were structured according to 
three thematic clusters: 1) representation and legitimacy, 
2) accountability and 3) operational considerations. These were 
followed by a fourth discussion during which participants sought 
to translate the concepts and issues raised into “best practices”. 
For each theme, a selection of guiding questions was provided. 
These were intended to stimulate conversation, but not confine 
the dialogue; participants were, therefore, free to address 
the questions or ignore them according to their perceived 
relevance. The list of guiding questions can be found in Box 1. 
Online virtual working meetings were held concurrently with 
each MESH-hosted discussion to provide an interactive venue 
for participants to address these topics openly, and to encour-
age the participation of those less able or willing to contribute to 
writing due to time, language, or other constraints. The combina-
tion of MESH-hosted discussions and virtual working meetings 
Box 1. Guiding questions
MESH-hosted discussions were structured according to three 
thematic clusters (listed below), followed by a fourth discussion 
during which participants sought to translate the concepts and 
issues raised into “best practices”. For each theme, a selection 
of guiding questions was provided. These were intended 
to stimulate conversation, but not confine the dialogue; 
participants were, therefore, free to address the questions or 
ignore them according to their perceived relevance. These 
questions are included here for reference. They were elaborated 
by Target Malaria and the Emerging Ag facilitating team on 
the basis of challenges faced by the project in the past or 
concerns raised by stakeholders or media in the dialogue on 
this research.
Representation and legitimacy
How are communities defined and delimited? Who is considered 
a member of a specific community and who isn’t? Who makes 
those judgements?
Are there criteria to determine whether “representatives” or 
“representative groups” are truly representative of the interests 
and composition of a community? What can or should Target 
Malaria do in cases where this is found not to be the case?
How can tensions between culturally-appropriate 
representation and decision-making models and representation 
of vulnerable groups be addressed or managed?
How should the project engage with members of the 
community who may be opposed to the research? Mainly if their 
opinions are determined not to be representative of those of 
the community?
How should the project engage with stakeholders who may 
not be part of the community, and so may not be obliged to 
consent to research, but who nonetheless feel they have a 
stake? For example, non-local NGOs opposed to GM research?
Accountability
What baseline obligations do project research teams have 
towards stakeholders when seeking community consent? How 
will these obligations change over the course of a project’s 
lifetime?
How can Target Malaria assess whether they are currently 
falling short of any of these obligations? What are the most 
appropriate mechanisms for doing so?
How can Target Malaria ensure that the complaint processes 
and grievance mechanisms established are effective and 
inclusive?
Under what circumstances is it beneficial to involve actors 
external to the project (and who may not be directly affected 
stakeholders) in the consent process? Who might those actors 
be? Should they be involved during the information sharing 
process in order to address perceptions of bias (i.e. concerns 
that those developing the technology are the only ones 
providing information about it?
What role should external auditors/certifiers play in project 
activities related to the consent-seeking process?
Operational considerations
How can Target Malaria’s current or planned approaches to 
seeking community consent be adequately scaled to different 
sized releases?
What adaptations or changes may need to be made, and how 
can these be done without undermining the legitimacy of the 
process and decisions?
Once consent has been obtained, are there further roles for 
the community to play in Target Malaria’s research? If so, what 
should they be?
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process, with all relevant stakeholders having provided 
informed approval”.
Identifying the relevant stakeholders and communities 
with which to engage. One of the most challenging topics that 
participants discussed was determining the relevant commu-
nities whose agreement must be sought for each phase and 
stage of research. The self-sustaining characteristics of some 
gene drive technologies (such as the ones considered by Target 
Malaria) make this particularly complex, as the members and 
delineations of relevant stakeholder communities may change 
over time as the gene drive intervention persists in the environ-
ment and/or spreads spatiotemporally. It was noted therefore that 
while the geographic location of stakeholders is essential, the 
stakeholders’ relationship to the ecologies and landscapes in 
which the species targeted by a specific gene drive intervention is 
embedded also may need to be considered. A distinction was 
drawn between relevant communities – those with tangible 
and immediate interests in Target Malaria’s work and/or who 
bear substantial and immediate risks related to it – and the 
general public. This is in line with definitions proposed by 
Lavery et al. (Lavery et al., 2010) and the National Academies 
of Sciences, Engineering, and Medicine (National Academies of 
Sciences Engineering and Medicine, 2016). Although research-
ers may not be obliged to seek the agreement of the general 
public for research to proceed, Target Malaria may wish to 
engage in less intensive, but parallel and complementary forms 
of outreach, such as disseminating information about the 
research through mass media, keeping an open dialogue with 
this public and consulting with regional and national authorities.
With regards to relevant communities, further consideration 
was given to the differences that could exist between residents 
of areas where research activities take place, including poten-
tial release sites for field evaluations, and residents of areas 
where research activities do not take place directly but which 
would be included in the monitoring area after releases of gene 
drive-modified mosquitoes (see Figure 1). Participants consid-
ered whether the concept of “bystanders”, as outlined by Walen 
(Walen, 2020) would be applicable to the work of Target 
Malaria. This definition would draw a distinction between 
those residing in an area potentially affected by a gene drive 
field trial (bystanders) and those who interact directly with, or 
host, research activities. The requirements for agreement from 
the former may be lesser. Some participants contended that this 
definition would be irrelevant in the case of trial gene drive 
releases, as there are no specific human beings who are directly 
experiencing the intervention so that all stakeholders would be 
bystanders. While Walen’s definition may hence not be directly 
useful, participants agreed that the challenge posed by gene 
drive-modified mosquitoes which, by design, are intended to 
spread geographically and establish themselves beyond the 
release points, requires careful consideration of how to determine 
the scope of the relevant communities. While all communities 
in the area impacted by the research should be engaged and 
informed, it was suggested that the model for agreement and 
representation could be different for communities in release 
sites and those in the monitoring areas. Researchers could work 
Best practices
   Drawing on previous discussions, are there best practices for   
seeking community consent that can be identified that are of 
particular relevance to Target Malaria?
  Do any of these best practices need to be prioritised over others?
   Are there issues or considerations related to community consent 
that still require further work or reflection on behalf of Target 
Malaria to resolve?
   Are there other projects or processes, or other relevant 
organisations, that have drawn-up benchmarks or frameworks 
that could inform Target Malaria’s work?
   What roles and responsibilities can ethics committees be expected 
to take on, and how can this be reflected in best practices? What 
about national authorities?
allowed the greatest possible range of participants to 
contribute actively. Virtual working meetings were hosted on 
Zoom and accompanied by an interactive visual hosted on 
Mural that all participants had access to. In between virtual 
working meetings, participants were invited to make further 
comments or changes on the Mural visuals to reflect any 
additional points they wanted to make. All findings were drawn 
from the MESH-hosted discussions, the interactive MURAL 
visuals, and notes taken during the virtual working meetings.
Workshop findings
Findings are presented according to the key themes that arose 
in the course of discussions.
Appropriate conceptual terminology: The term “consent” 
has particular connotations in the realms of ethics and clinical 
trials that may not be appropriate to transpose from the field 
of health research with human participants to field experi-
ments involving gene drive-modified mosquitoes, as this under-
standing of consent is rooted in notions of individual rights and 
autonomy. Free prior and informed consent” (FPIC) is another 
conception of consent related to collective approval that is preva-
lent in (among others) the realms of conservation and the rights 
of indigenous peoples and affected communities (George et al., 
2019). This connotation of consent is also less appropriate to 
the work of Target Malaria, as the project is not currently active 
in areas where there are recognised indigenous peoples and 
the conceptual definitions that underpin its work should be 
applicable to all relevant stakeholders not merely those directly 
affected by its efforts. In light of this, participants found 
that “community agreement” was the least ambiguous and most 
fitting conceptual terminology for Target Malaria to seek from 
relevant communities before engaging in research that may 
impact them. Participants felt that “community agreement” 
implied a two-way discussion between relevant stakeholders and 
the project in which stakeholders have a more significant influ-
ence in helping to define the terms and expected outcomes of the 
engagement process, in contrast with other terminologies (such 
as “community acceptance)”. When attempting to determine 
what constituted “community agreement”, participants settled 
broadly on “permission provided for research activities to proceed 
according to conditions negotiated during the engagement 
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Figure 1. Areas of differing stakeholder engagement.
in a more devolved or mediated model with the monitoring 
area communities, for example, through local authorities to share 
information and gather feedback from those communities on 
research activities. These authorities could be key to brokering 
community agreement.
Once relevant communities have been identified at the theoretical 
level, there remains the often-challenging task of translating 
theory into practice. Participants agreed that the stakeholders 
from the relevant communities, whether the project activity 
that concerns them is direct research, monitoring, or something 
else, must be involved in decisions that delineate the bounds 
of their communities and in designating their own representa-
tives. In doing this, project teams must strike a balance between 
consulting those recognised as having authority delegated to them 
by the community (elders, headmen, elected representatives etc.) 
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and taking into account cultural or communal biases that may 
lead to the neglect of concerns expressed by some stakeholder 
groups (for example women, ethnic minorities, those with 
disabilities). Relevant authorities who could play an advisory or 
decision-making role may include national regulatory agencies 
and ethics committees, formal and informal community leaders, 
representatives of marginalised groups and others.
Formative research, including anthropological research, to 
understand demographic and institutional profiles, social and 
cultural mores, relationships of power etc. should help inform the 
community engagement process. Engagement with authorities 
and other community representatives should not preclude 
broader forms of engagement with the community as a whole 
(radio broadcasts, town halls meetings, didactic theatre perform-
ances, etc.), which can help ensure that information is sufficiently 
disseminated and decisions regarding any community agree-
ment are adequately informed and can help prevent the spread 
of misinformation
Remaining questions for further discussion:
     •      How is a community defined? It was determined that 
further information and research is needed before the 
workshop participants would be able to articulate a 
broad consensus. The concept of community has been 
discussed for genetically modified mosquitoes' field release, 
including that of gene drives, and some definitions have 
been suggested (James et al., 2018; National Academies 
of Sciences Engineering and Medicine, 2016; Resnik, 
2018). However, because Target Malaria’s research on 
gene drive-modified mosquitoes is still in the laboratory 
stages, the rate of geographical and temporal dispersal of 
such mosquitoes is unknown at this point. The develop-
ment of models for the spatiotemporal spread of future gene 
drive-modified mosquitoes for field trials will depend 
on a number of variables, including release protocol, 
the characteristics of the gene drive-containing DNA 
construct, and ecological factors. All of which may evolve 
over time as the research project progresses. This will 
have profound implications for how relevant communi-
ties that need to be engaged for community agreements 
are defined. Indeed, if dispersal is great enough then the 
relevant communities may not share mutual interests, cul-
ture, or mechanisms of governance, straining the project’s 
concept of “community” and the ability of researchers to 
utilise a similar or generic approach for engagement with 
different groups. It was noted that this might be of more 
significant concern for the possible use of any devel-
oped technology, rather than during Target Malaria’s 
near-and-medium-term research activities, involving the 
releases of non-gene drive genetically modified mos-
quitoes that are self-limiting by nature and thus do not 
affect such a large geographical area.
Engaging with stakeholders who may not wish for the 
research to take place and taking their opposing views 
into consideration. As mentioned earlier, one of the signal 
challenges of testing area-wide vector control methods (such 
as those being developed by Target Malaria), is the inability 
of individuals within an agreeing community to opt-out, due 
to the nature of the technology. During the process of seeking 
community agreement, venues and channels must be available 
for those opposed to the research going forward to voice their 
opinions to researchers and other stakeholders. This is com-
mon in any kind of community engagement effort (International 
Finance Corporation, 2007; Wood, 2011). The community 
agreement brokering process, including the avenues for express-
ing disagreement, must be elaborated ahead of the engagement 
process in consultation with the stakeholders themselves, to 
ensure that those who may not find themselves in accordance 
with the outcomes in the community agreement are at least in 
accordance with the process that produced it. Even after the terms 
of a community agreement are attained, those who disagree with 
the outcomes can provide valuable insight into the work of the 
project. A comprehensive engagement process can help build 
trust and perceptions of procedural justice by demonstrating 
that their perceptions were actively and seriously considered.
In addition to this critical process for decision making, itself 
the product of a method of dialogue between communities and 
researchers, it was noted that agreement achieved at one point 
in time should not be considered final and irrevocable across, 
and for the remainder of, the project. Research like Target 
Malaria’s takes place over years and agreement is sought from 
communities multiple times for many different activities along 
the research continuum over an extended period of time, not 
only at the moment of seeking to carry out field evaluations. 
Communities will have multiple and renewed opportunities to 
seek changes to the terms of a community agreement or to end the 
agreement. Therefore, the community agreement process should 
be thought of as a dynamic engagement process with multiple 
decisions and agreements that offer multiple opportunities for 
different views to be expressed, heard, and negotiated. 
Remaining questions for further discussion:
     •      What if the geographical scope of a field trial encom-
passes a large enough number of people that they would be 
considered multiple communities according to the criteria 
outlined in "remaining questions for further discussion" 
above? In this case, if communities were to differ as to 
the acceptability of the research taking place, a legitimate 
and culturally conversant mechanism for intra-community 
deliberation would need to be elaborated. What shape such 
a tool might take would require further work. This may be 
a significant issue; however, this is not urgent, as experi-
mental trials on that scale involving gene drive-modified 
mosquitoes are unlikely to take place in the medium-term 
future. This would only be relevant for activities which 
would affect all communities in a field trial site.
Monitoring mechanisms. Of equal importance in determining 
who should be consulted and on what terms, is the question of 
how the terms of a community agreement can be monitored or 
verified to hold researchers accountable for fulfilling their respon-
sibilities. Monitoring mechanisms independent of researcher 
project teams can help minimise perceived or actual conflicts of 
interest. On the other hand, independent monitoring by exter-
nal entities may contribute to undermining community trust by 
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creating the perception that their feedback and monitoring 
methods alone are insufficient to confirm compliance with the 
terms of the community agreement. In addition, independent 
monitoring activities may contribute to a perception that 
researchers are engaged in the form of legal or regulatory 
“box-ticking” for the benefit of other stakeholder audiences, not 
for the benefit of the community itself. Therefore, any monitor-
ing mechanisms must be established in active consultation with 
affected communities and should be part of the agreement 
negotiated with the community. The need for such independent 
monitoring will depend heavily upon the context in which the 
research is taking place, and relevant external authorities may 
include governmental regulatory authorities, third party NGOs, 
professional auditors, community advisory boards and others. 
In some cases, such third parties are well established and 
have a predefined monitoring role (for example national biosafety 
authorities), in other cases, they may need to be identified or 
created (such as community advisory boards, external professional 
auditors). Some practitioners noted that the lack of an external 
authority has in the past led to perceptions among stakeholders 
of a lack of appropriate oversight.
Target Malaria is one of the first projects to work on gene 
drive approaches for malaria control, and it is likely to be the 
first of its kind to work through some aspects of stakeholder 
engagement and community agreement related to this technol-
ogy. As such, the project’s experiences and reflections related 
to the process of seeking community agreement are likely to be 
extremely valuable to other gene drive researchers in future. 
Therefore, participants felt that in addition to its own internal 
tracking and documentation processes, Target Malaria might 
find working with an independent evaluator of its stakeholder 
engagement and community agreement efforts to be 
valuable.
Remaining questions for further discussion:
     •     How will the appropriate criteria and benchmarks be 
selected and by whom to ensure an evaluation process 
is useful?
     •      What parameters will ensure that the evaluation will be 
sufficiently independent? External sources of funding 
for an assessment may be minimal, whereas having the 
evaluation funded by the project itself risks calling into 
question its autonomy.
Operationalising these considerations. Participants were 
asked how the workshop findings discussed above could be 
integrated into a model of Target Malaria’s engagement and 
community agreement seeking processes. A visual model 
reflecting the outcomes was developed, which can be found in 
Figure 2. It establishes the pre-conditions necessary for suc-
cessful community engagement and lays out two separate 
pathways for engagement depending on whether the com-
munity in question will be directly or indirectly affected by 
research activities while identifying the relevant actors for 
each stage in the engagement process.
Conclusion
During this workshop participants helped identify good 
practices and key considerations that Target Malaria can 
incorporate into its stakeholder engagement and community 
agreement-seeking processes as it moves forward with its 
research, as well as areas in which further thought and greater 
conceptual clarity are needed. These considerations are likely to 
be broadly applicable to many different gene drive research 
projects, as well as research involving field releases of genetically 
modified insects.
Key workshop considerations are summarised below:
     1.      Appropriate conceptual terminology: Participants found 
that "community agreement" – defined here as permis-
sion provided for research activities to proceed according 
to conditions negotiated during the engagement process, 
with all relevant stakeholders having provided informed 
approval – was the least ambiguous and most fitting 
conceptual terminology for Target Malaria to seek from 
relevant communities.
     2.      Identifying the relevant stakeholders and communities 
with which to engage: 'Relevant communities' and the 
'general public' were deemed distinct, and, for Target 
Malaria, relevant communities were further delineated 
as sites for field evaluations and areas where monitoring 
may take place, with particular models of stakeholder/ 
community engagement in the two.
     3.      Engaging with and taking into consideration opposing 
community stakeholder views: Target Malaria's commu-
nity agreement process should be thought of as a series 
of multiple engagements, decisions and agreements 
that offer opportunities for the full range of views to be 
expressed, heard, and negotiated.
     4.      Monitoring mechanisms: Monitoring mechanisms 
independent of Target Malaria activities can help 
minimise the perception of or actual conflicts of interest.
     5.       Operationalising these considerations in practice: See 
Figure 2.
In addition, participants identified areas in which further thought 
and greater conceptual clarity are needed.
     •      How is 'community' defined?
     •      What if the geographical scope of a field trial 
encompasses a large enough number of people that they 
would be considered multiple communities?
     •      How will the right criteria and benchmarks be selected 
and by whom to ensure a monitoring evaluation process is 
useful?
     •      What parameters will ensure that a monitoring evaluation 
will be sufficiently independent?
Beyond the specific conclusions of this workshop, it was an 
opportunity for participants to share their knowledge, 
perspectives and opinions on this crucial topic of community- 
agreement seeking for gene drive field evaluation. Several 
participants volunteered to be consulted again in the future about 
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Figure 2. Operational model.
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the model or about specific aspects of it, such as some of the 
points highlighted for further discussion. For Target Malaria, 
KEMRI and PAMCA, this was a chance to start creating a 
community of practice with experts from the African continent 
and beyond, who could be further consulted on this issue in the 
future and who through time are building a shared understanding 
of the subjects at hand. The adaptation of the workshop 
format from an in-person meeting to a virtual meeting due 
to the coronavirus disease 2019 (COVID-19) pandemic created 
challenges for the format but has allowed broader participation 
from experts who might not have been able to dedicate three 
consecutive days to travel to an in-person meeting.
Data availability
Underlying data
No data are associated with this article.
Acknowledgements
The authors would like to thank Guilherme B. Costa (World 
Mosquito Program Brazil, Rio de Janeiro, Brazil) who also 
participated as part of this workshop. In addition, gratitude goes 
to the team from Emerging Ag who facilitated the workshop and 
adapted its format to the new circumstances of the COVID-19 
pandemic.
References
 African Union: Gene Drives for Malaria Control and Elimination in Africa. 
2018.  
Reference Source
 Barry N, Toé P, Toe LP, et al.: Motivations and Expectations Driving 
Community Participation in Entomological Research Projects: Target 
Malaria as a Case Study in Bana, Western Burkina Faso. Malar J. 2020;  
19(1): 199.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 Feachem RGA, Chen I, Akbari O, et al.: Malaria Eradication within a 
Generation: Ambitious, Achievable, and Necessary. Lancet. 2019; 394(10203): 
1056–1112.  
PubMed Abstract | Publisher Full Text 
 George DR, Kuiken T, Delborne JA: Articulating ‘free, Prior and Informed 
Consent’ (FPIC) for Engineered Gene Drives. Proc Biol Sci. 2019; 286(1917): 
20191484.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 Hartley S, Thizy D, Ledingham K, et al.: Knowledge Engagement in Gene Drive 
Research for Malaria Control. PLoS Negl Trop Dis. 2019; 13(4): e0007233.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 International Finance Corporation: Stakeholder Engagement: A Good 
Practice Handbook for Companies Doing Business in Emerging Markets. 
International Finance Corporation. 2007; 201.  
Reference Source
	 James	S,	Collins	FH,	Welkhoff	PA,	et al.: Pathway to Deployment of Gene Drive 
Mosquitoes as a Potential Biocontrol Tool for Elimination of Malaria in  
Sub-Saharan Africa: Recommendations of a Scientific Working Group†.  
Am J Trop Med Hyg. 2018; 98(6_Suppl): 1–49.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 Lavery JV, Tinadana PO, Scott TW, et al.: Towards a Framework for Community 
Engagement in Global Health Research. Trends Parasitol. 2010; 26(6): 279–83.  
PubMed Abstract | Publisher Full Text 
 National Academies of Sciences Engineering and Medicine: Gene Drives on the 
Horizon. 2016.  
Reference Source
 Resnik DB: Ethics of Community Engagement in Field Trials of Genetically 
Modified Mosquitoes. Dev World Bioeth. 2018; 18(2): 135–43.  
PubMed Abstract | Publisher Full Text 
 Thizy D, Emerson C, Gibbs J, et al.: Guidance on Stakeholder Engagement 
Practices to Inform the Development of Area-Wide Vector Control 
Methods. PLoS Negl Trop Dis. 2019; 13(4): e0007286.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 Walen A: Using, Risking, and Consent: Why Risking Harm to Bystanders Is 
Morally Different from Risking Harm to Research Subjects. Bioethics. 2020; 
34(9): 899–905.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 WHO/TDR, FNIH: Guidance Framework for Testing Genetically Modified 
Mosquitoes. 2014; 159.  
Reference Source
 Wood A: Overview of Ngo – Community Complaints Mechanisms. 2011.  
Reference Source
 World Health Organization: Position Statement Evaluation of Genetically 
Modified Mosquitoes for the Control of Vector-Borne Diseases. 2020a.  
Reference Source
 World Health Organization: WHO Guidance, Ethics and Vector Borne 
Diseases. 2020b.  
Reference Source
 World Health Organization: WHO/HTM/GM World Health World Malaria 
Report. 2020c.  
Reference Source
Page 11 of 15
Gates Open Research 2021, 5:19 Last updated: 12 APR 2021
Open Peer Review
Current Peer Review Status:   
Version 2
Reviewer Report 12 April 2021
https://doi.org/10.21956/gatesopenres.14454.r30517
© 2021 Evans S. This is an open access peer review report distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Sam Weiss Evans   
Program on Science, Technology, and Society, Harvard University, Cambridge, MA, USA 
The authors of this Open Letter outline the work that they have done to build capacity for 
community engagement that can lead to "community agreement" for the field testing of gene 
drive mosquitos.  
 
As a workshop report, this paper seems adequate, but there are important gaps that this paper 
does not address which bear mention here in this public peer review. They fall under two basic 
categories:
We should not assume that democratic engagement at the point of field trials could result 
in meaningful reconfiguration of the technology itself; and 
1. 
The lack of attention to the opposite of "community agreement" means that there is no 




Gene drive work is necessarily political as well as technical, and thus is as much about re-forming 
the social orderings within a community as well as the technical orderings in it and the 
environment around it. The authors' attention to the construction of the "community" 
appropriately captures this dynamic, if not calling it out directly. While attention is given in the 
letter to ensure that the authority of local forms of government are acknowledged even as they 
are reconfigured in the process of reaching "community agreement," it is unclear how much 
attention there is to the authority of those local forms of government's ability to re-form the 
technologies under consideration. 
 
The choice of what types of political arrangements are acceptable to the authors is shown at 
several points, with a strong preference for various forms of democratic input (e.g. stakeholders 
accepting the process of deliberation even if they do not accept the outcome). 
 
One of the elements that appears to be missing in this paper is attention to feedback loops 
between communities and actual research design. There are several points in the paper where the 
focus is (appropriately) on the feedback loop on the ways that the engagement effort itself is 
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structured, but not on how feedback reaches further back to lab development work.  
 
As a community engagement paper specifically around the moment of decision-making on field 
trials, this may be adequate, but that would assume that earlier feedback loops on research 
design and lab development also took place. There was no mention in the paper of any such prior 
engagement leading to feedback and alteration of research designs, leading the reader to assume 
that this is a technology developed in the West and tested in the global south, an accusation I 
suspect the authors are keen to counter. The Hartley et al. paper cited only notes that "tools to 
track knowledge flows from publics to scientists are less developed." They note that Target 
Malaria was, in 2019, setting up an "ecological observatory" in Ghana, but this was still 
preliminary. The Thizy et al. paper was a general statement about the need for early and 
continuous engagement, but with no specific examples on how Target Malaria was actually doing 
that.  
 
There was also no discussion of what would count as the opposite of "community agreement" - 
that term is solely reserved for "permission provided to research activities to proceed." There is no 
option, for example, for there to be "community agreement for research to not proceed." This lack 
of an alternative decision to a "yes" means that there is no clear method for there to be a 
definitive "no."  
 
In short, there is a strong assumption of the value of community input through means that place 
the community on an epistemic par with the researchers at a specific point in the research lifecycle 
for gene drives: the initiation of field trials. 
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This is a very useful and important study about how to do fair and effective community 
engagement for field trials of genetically modified organisms.   
 
The information obtained from this workshop will be useful to others who are planning 
community engagement activities. The article is well-written and well-researched.   
 
I have no suggestions for improvement and look forward to its indexing.
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